EXICURE, INC. Increase (Decrease) in Other Noncurrent Liabilities
EXICURE, INC. (XCUR) reported Increase (Decrease) in Other Noncurrent Liabilities of -$119.00 thousand for the 9-month period ending 2020-09-30, per its 10-Q filed 2020-11-12.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2020-11-12
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-09-30 was -$60.00K.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-06-30 was $0.00.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-03-31 was -$59.00K, a 117.30% decline year-over-year.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-12-31 was -$86.00K.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was -$322.00K.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2018 was -$239.00K.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2017 was -$3.00K, a 250.00% decline from fiscal 2016.
- EXICURE, INC. increase (decrease) in other noncurrent liabilities for fiscal 2016 was $2.00K.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2020-09-30 | -$60.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$60.00K derived: sum of 2 quarters · filed 2020-11-12 | -$119.00K 10-Q · filed 2020-11-12 | -$205.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$59.00K 10-Q · filed 2020-08-12 | -$145.00K derived: sum of 3 quarters · filed 2020-08-12 | -$187.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2020-03-31 | -$59.00K 10-Q · filed 2020-05-14 | -$145.00K derived: sum of 2 quarters · filed 2020-05-14 | -$187.00K derived: sum of 3 quarters · filed 2020-11-12 | -$722.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$128.00K derived: sum of 2 quarters · filed 2020-11-12 | -$663.00K derived: sum of 3 quarters · filed 2020-11-12 | -$322.00K 10-K · filed 2020-03-10 |
| 2019-09-30 | -$42.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$577.00K derived: sum of 2 quarters · filed 2020-11-12 | -$236.00K 10-Q · filed 2020-11-12 | -$238.00K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | -$535.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12 | -$194.00K 10-Q · filed 2020-08-12 | -$196.00K derived: sum of 3 quarters · filed 2020-08-12 | -$429.00K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $341.00K 10-Q · filed 2020-05-14 | $339.00K derived: sum of 2 quarters · filed 2020-05-14 | $106.00K derived: sum of 3 quarters · filed 2020-05-14 | $103.00K derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-10 | -$235.00K derived: sum of 2 quarters · filed 2020-03-10 | -$238.00K derived: sum of 3 quarters · filed 2020-03-10 | -$239.00K 10-K · filed 2020-03-10 |
| 2018-09-30 | -$233.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | -$236.00K derived: sum of 2 quarters · filed 2019-11-07 | -$237.00K 10-Q · filed 2019-11-07 | -$238.00K derived: sum of 4 quarters · filed 2019-11-07 |
| 2018-06-30 | -$3.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | -$4.00K 10-Q · filed 2019-08-08 | -$5.00K derived: sum of 3 quarters · filed 2019-09-23 | -$7.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2018-03-31 | -$1.00K 10-Q · filed 2019-05-08 | -$2.00K derived: sum of 2 quarters · filed 2019-09-23 | -$4.00K derived: sum of 3 quarters · filed 2019-09-23 | -$4.00K derived: sum of 4 quarters · filed 2019-09-23 |
| 2017-12-31 | -$1.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2019-09-23 | -$3.00K derived: sum of 2 quarters · filed 2019-09-23 | -$3.00K derived: sum of 3 quarters · filed 2019-09-23 | -$3.00K 10-K/A · filed 2019-09-23 |
| 2017-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | -$2.00K derived: sum of 2 quarters · filed 2018-11-06 | -$2.00K 10-Q · filed 2018-11-06 | -$1.00K derived: sum of 4 quarters · filed 2018-11-06 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-06 | $0.00 10-Q · filed 2018-08-06 | $1.00K derived: sum of 3 quarters · filed 2018-08-06 | |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-15 | $1.00K derived: sum of 2 quarters · filed 2018-05-15 | ||
| 2016-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $2.00K 10-K · filed 2018-03-09 | ||
| 2016-09-30 | $1.00K 10-Q · filed 2017-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |